{"id":949972,"date":"2026-04-08T16:10:32","date_gmt":"2026-04-08T20:10:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/"},"modified":"2026-04-08T16:10:32","modified_gmt":"2026-04-08T20:10:32","slug":"annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","title":{"rendered":"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BRISBANE, Calif., April  08, 2026  (GLOBE NEWSWIRE) &#8212; Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president and chief executive officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026 at 11:45 a.m. ET.<\/p>\n<p>A live webcast of the event can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zptdpe7lPUmdyPBoyfm22IjnSAe5h4VbLqE4hJWrC2NXuTT4KSz7Qxey8IeV2nOqWW2-WU5tVJA4TTQh0kQ0LRLPw0NOdMzJUOe8Y_dr98RbL7G90YIp0WFnNYsPvftD4GgVOhOJpnJsoHa6f7ai-TQY74nQTmqaMRW0TtCrp3-Bg0zFaJbQVSZz3IKidcjkJjwx6N4KRa2mw0mZg02rfxDb0lGa08bcrQcMDYxg1MKObwJkNhBc_A4BwA0IUdXO1DIAkEyG7y3QmvoUZ-QxzBuyji_yoDfZMtO8zonmYHrUv302AwRWt6cYdat_Q9KdQEjGpmJFt9TbqAn8AD8406Qywmv8Ix0gDDrxp54XsdFJyn8WejatyW6rBCQQZwsqPGEYpWxyxIS9uMsKS3xLyCzpyL3M554pUAk_3B2QKY3aU-xBi6t-UuVT-D_DTpBUt__zF56ySHE8LGy0KH3PsSJEFBw621SgTIiJYZ7RY7pB99emU1G91Sg_Rid1ZXknY0rDqCV9hMUfvjvWTOP59zCjObRdw1CUyI-6WaC9UPd7GEW3SbGxoBdEcaHNbfL40XFlYyeu7qGIe_1D5HMBe8JqK0XKbyMB-JkiMjLOLTxQmJ3N8biyeud38-LRkfCOFSQOgOebEhjaLkZM4jpxud9VZs-fZ1YBdoielVGF0hG4VeGyWpo9bspmdhXZMPLa-d4v_kRnDMw5fMqZvkzZMrKoQxhT9tMgTP1b_bJb00h19_4RQc6qP15zNT1UAFS7HNqaW555Ju51cFv6TmxFEdSTzNUqpV5J_uPMPvhZTaYoRbUHTx2Ir8eXGIxfZwJTe-G9tU-UcQuFFhIfyMb3jAxGuEYTRUrXGEYvDrL3MtiZ46k8r-ejeLiHE97LHAwi-vyxyd2TM1_bYwvq-aWHW06UqMPN2tqGFUviCwfTPZCl3QmUu4ngpetBVXFlgmq7FEiVpqYlsgMTnO8Tja8I0u53dB4pVPhTmAinRCuR4WHG3xiTEHL_uMn4QJFrMZlVw0M2qmtyzhTevSk-RdkZQf2ydCojQmXfCGoi3dw2exTlW1mBqpMQJVwFAiq-b22o3Dwk_spJ-NWlgzP4shAo4MbiyzQ0EcTrUHTXTa_q60dzJDwxCVXi34svOOhFgZjkyXZVkyyuY1CV2T-R5bTPC8jw-RJk6vRoizZOm_5zq4LlhZzvBnU2qwngvk0AsKYCw4mMgXI4gOD7gDttsZBtu3ZMY7XqE5v_8lPQVqzgJEX-s5F0mpnv6CFSYpkc_FVOLDwiZS2l7333lQyBDtRQRHOxl1lM5URcO29vxU3E2HTjb2XkVOn9Cgq0rRRf_u0QfQXKT7TLDRltFpcwZ-zlc4GqawokELPgrrGmnULDGwJybslO3abZimhC72cGb26w4p2C1EVG1gy31nxnFt382VBj2QhZ8_5PZyO_bbRBmgIfFLzyUlCO2syhOF-f8mv5ZHH9EudVcRPG3UUFomdKZLAmjhmHE9_khik-95RacoXnH8ti4dux92i7ljg8SkZExg87pg6q3uI1P9FMbkiMcSaF622kI_61UUSEb8OdMcKrSx017FfMtkEPgh6871oETEnAEG_eCkoToOoJY3GvTfPCQdwZVyj4hQY4Kvk8F6a-7_SuxRumbmgtB0FgKQQSnlZJkrVOcK_zlHXQ5KrDiAevOIncpTp2btjy5zOmMBsJ9CsXE5QmWJfz0Eg6bhRy9v89FnCii0Gi2mopSLSw0SIqpGi0Ogm0GiCFiTHToPoEWYyREvaeG1V8CTbzaVXRkx-_aoAh94CkgI4_emKQ0ust63RLCheTCRLDqwn7npPL4CEJpAkfo32bUz640v_0HNDuxEItHy9w4q00OrO6clBfFH-S6ePQyJ3FTUM-6FzhLzxrBlaj0p4Muqt9MjH1friuCK38-10fF5J7vSKA4UyHSJEyA_lAp_y6ECuWWGa1HFaWsuF0Cv-uPCKiX6uGeShVRn05C5Z4CJeunpg4QIYQP3jmu8nFaW8Ad9p1wYmKukg10The1VvSddOmBIb5ePRPZU6Ni1ngb_zNzIn16GgauDoq88t94iaqOZCkM193UNNfk5PMg9Dxc2Nuf_1JeYi8rTvp1ErGPXUfYnXIxJ5Fr-_l0vc4wPcsKJ-Ddzr0dbYOhoSyQsE6uxH2wOnEOssEKGGhl2WiQwStCTMHs2O-RLDMYOaQig8oVZdpFZanGN8vIBkOY3USflj4AIANQqiSH6u7O2yQjQBZqVnOAn6HJjJdmJ1T5rofDRiTu08t2bGmGXboKDwZKubHQLseT9ZBeN4zbbo-ocz3oTDyZr13WViOqyWf9TcSc9PnpNJQSE2dGBq5pQAxW4te3VZb\" rel=\"nofollow\" target=\"_blank\">www.annexonbio.com<\/a>. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation.<\/p>\n<p>\n        <strong>About Annexon<\/strong>\n      <\/p>\n<p>Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 million people worldwide living with serious neuroinflammatory diseases. Our founding scientific approach focuses on C1q, the initiating molecule of a potent inflammatory pathway that when misdirected can lead to tissue damage and loss of function in a host of diseases. Our targeted therapies are designed to stop classical complement-driven neuroinflammation at its source to provide meaningful functional benefit and alter the course of disease. Annexon\u2019s mission is to deliver game-changing therapies to millions of patients to help them live their best lives. To learn more visit annexonbio.com.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Joyce Allaire<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v2wSr-nh24yjw5C54mk3xsUCQzY7K8cn6Fb-xb8mGo8SPWDhtjHZXp-Dn90SMNeBlFxtk_bmU8m3DKBasiQyboatfR4A0st2jQLqjSFjlIU4IbWnNNH28E2LGXTeQ2zZuYQhoIMiTcsFzqZ-UpriysyPuJtgvU683wetP63TrkI_QEdNd_NOFlGOiBNphpVDoXc7ALCNZncEbKVHE1rRBAkiKmK9zcPj6nB5I0fMRP2yTbSf7YAF2R7evlR3HcEuVNWHLTP08DbkmfFHOWBL_E4nbA0wY4LS7sbf7C8oOeHvEeSbFsS7FVCDxtqDvUpFRDnlysC9AMoSiLsLfQB6hAtZK4GJb9qqz_uoW0e4Ekdh-cnD8-GKAZD9UhdlCaeeblxjF__zj0I5P8_BZiF2OJfM5RaQYr41yjPKq3hWh-Tqn3ipGh_KHVVWrG5U4nIKzaqfcjTUDa_ypkpwLOspDn9En-3mR8VMLAA5GHsbiFkyXkKuSsfKhGLgiFXPuOYgRQhSA5IpQ7lJUfwjpwkym2_boVkyVvl6Gsu-1jDvav-PDkw0aOXElznRIHptUAay\" rel=\"nofollow\" target=\"_blank\">jallaire@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Beth Keshishian<br \/>917-912-7195<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TiGhJsch9PFWhz2YVKoDvkjITJMhjMMqqNiz3PYKP914JPzV_JSsB84jQnYU7Iw8s5anbMgAO0vJes-8A42gdSSYjZRyjxU0pT16LFMJAdrVRuB5PkvCCz6Hz4ie5Aq9ivdhVfxEZGXwKGKi1FSe0iDQlgq9uLRG-fuNXsFQCVRqCVQEYXuq5bjQLLxLtyeTiZdj1L2gg0LtDpPCwS8_0SvCqn_nSXUVfpUvpXCz7pheEHUJKXwhh7VWKsho5oHCgpE7XhYyHlVPl6J9HF4ghyrY1aCzcFgr5qdu-IMOZq0DpuuO9nYMN4iwd0pdYc3dCal_gGuvdNiMNPbW8A6AvxrmWxg3295axn9g76xCeOjEvVIR81xXpz_xkfvcyR4QxvTtpd8uf9PFNV_F-Zm8PPPwKYbIJ74PM-z6L71aFvCFdCmLtGorIal6-Z837RqWnZK1Ax173hIYBhmgRvQK92Q_BPKoib21ZKOJ3g4JYt2iTTUUz_kL0j5mPpZX9VAeeX28tXGfaxr5o-56kKc9Jrm2Ph1MkmRg2SkRI_wGOc8TL3iAWOcGtkwrNly6pwB-uOrwAZ63uF40nGJYrmu-BZYWbK46TM9Hg6MIYtcj0nbYJLzH2PWp95gnkVybVTKmOPjPpaQVZbZzjS-KCGfRvHwXkY8x9I6o5qkGNidh23Ho72xMO3HW0W8nmh-zzngyp-ndHbg1xJQ26qMvK99kdJ9bxKiPeBcHwlc1S_nqPtWF2tKvTF9FTQwgXP209eogaqEs6AgqrkPEtFyDA4goKmSxTkxgj1dD1AJhjfjWE3j2ovgFQXDWORVVARFTF2YRef-mnhY7WTrH7hZFmP4_WQ==\" rel=\"nofollow\" target=\"_blank\">beth@bethkeshishian.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmYzOTQzMWQtZWJhMy00NjNjLTkyYjItYWQ5OTcyYWVmZWM3LTEyMDE2NDUtMjAyNi0wNC0wOC1lbg==\/tiny\/Annexon-Biosciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president and chief executive officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026 at 11:45 a.m. ET. A live webcast of the event can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at\u00a0www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. About Annexon Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-949972","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president and chief executive officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026 at 11:45 a.m. ET. A live webcast of the event can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at\u00a0www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. About Annexon Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 &hellip; Continue reading &quot;Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-08T20:10:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference\",\"datePublished\":\"2026-04-08T20:10:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\"},\"wordCount\":234,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\",\"name\":\"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=\",\"datePublished\":\"2026-04-08T20:10:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk","og_description":"BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president and chief executive officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026 at 11:45 a.m. ET. A live webcast of the event can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at\u00a0www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. About Annexon Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 &hellip; Continue reading \"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-08T20:10:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference","datePublished":"2026-04-08T20:10:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/"},"wordCount":234,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","name":"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=","datePublished":"2026-04-08T20:10:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjQzNiM3NTI2MTg2IzIxOTAwOTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=949972"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949972\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=949972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=949972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=949972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}